COMPOSITION FOR THE PREVENTION OR TREATMENT OF NEURODEGENERATIVE DISEASES
First Claim
Patent Images
1. A method for the treatment or amelioration of a neurodegenerative disease, the method comprising:
- administering to subject in need thereof an aqueous composition comprising;
a. at least one xanthophyll andb. a hydrolysate of a protein, comprising di- and tripeptideswherein the neurodegenerative disease is selected from the group consisting of dementia, Alzheimer'"'"'s disease, Huntington'"'"'s Disease, Parkinson'"'"'s disease, Multiple Sclerosis, and Amyotrophic Lateral Sclerosis, andwherein the protein is selected from the group consisting of lysozyme, ovomucin, ovotransferrin, ovalbumin, and casein.
1 Assignment
0 Petitions
Accused Products
Abstract
The invention is in the field of the prevention, amelioration or treatment of neurodegenerative diseases, in particular of dementia including Alzheimer'"'"'s disease, Huntington'"'"'s Disease, Parkinson'"'"'s disease, Multiple Sclerosis and Amyotrophic Lateral Sclerosis. The invention provides new compositions that allow an improved prevention, amelioration and treatment of such diseases. More in particular, the invention provides a composition comprising a xanthophyll and a hydrolysate of a protein, comprising di- and tripeptides.
1 Citation
16 Claims
-
1. A method for the treatment or amelioration of a neurodegenerative disease, the method comprising:
-
administering to subject in need thereof an aqueous composition comprising; a. at least one xanthophyll and b. a hydrolysate of a protein, comprising di- and tripeptides wherein the neurodegenerative disease is selected from the group consisting of dementia, Alzheimer'"'"'s disease, Huntington'"'"'s Disease, Parkinson'"'"'s disease, Multiple Sclerosis, and Amyotrophic Lateral Sclerosis, and wherein the protein is selected from the group consisting of lysozyme, ovomucin, ovotransferrin, ovalbumin, and casein. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 15, 16)
-
-
14. (canceled)
Specification